Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DURANEST

EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE

Standard Dose
0.005MG/ML;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DURANEST is listed in Drugs@FDA under application 017751 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.005MG/ML;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ASTRAZENECA Submission history Latest submission status date: 1999-03-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview DURANEST is listed in Drugs@FDA under application 017751 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.005MG/ML;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ASTRAZENECA Submission history Latest submission status date: 1999-03-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DURANEST (EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline